These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 9035147)

  • 1. Going beyond the native: protecting DNA and protein patents.
    Chahine KG
    Nat Biotechnol; 1997 Feb; 15(2):183-6. PubMed ID: 9035147
    [No Abstract]   [Full Text] [Related]  

  • 2. Genomics companies welcome US PTO initiative on DNA patents.
    Marshall A
    Nat Biotechnol; 1997 Feb; 15(2):121-2. PubMed ID: 9035129
    [No Abstract]   [Full Text] [Related]  

  • 3. Patent office resurrects EST debate.
    Chahine K
    Nat Biotechnol; 1998 Aug; 16(8):711. PubMed ID: 9702759
    [No Abstract]   [Full Text] [Related]  

  • 4. Protecting rights to early-stage technology.
    Shuster MJ; Su H; Blaug S
    Nat Biotechnol; 2003 Jun; 21(6):701-3. PubMed ID: 12776151
    [No Abstract]   [Full Text] [Related]  

  • 5. The coming US patent opposition.
    Apple T
    Nat Biotechnol; 2005 Feb; 23(2):245-7. PubMed ID: 15696151
    [No Abstract]   [Full Text] [Related]  

  • 6. German agencies sound alarm on risks of broad gene patents...as spending goes up for research.
    Schiermeier Q
    Nature; 2000 Jul; 406(6792):111. PubMed ID: 10910319
    [No Abstract]   [Full Text] [Related]  

  • 7. Are patents and research compatible?
    Ducor P
    Nature; 1997 May; 387(6628):13-4. PubMed ID: 9139814
    [No Abstract]   [Full Text] [Related]  

  • 8. Reexamining the research exemption.
    Flores MA; Campbell C
    Nat Biotechnol; 2005 Jun; 23(6):659-61. PubMed ID: 15940230
    [No Abstract]   [Full Text] [Related]  

  • 9. Beyond the letter of the law: the US Federal Circuit interprets section 271(g)(1).
    Tsao R; Hurley EA
    Nat Biotechnol; 1997 Jan; 15(1):86-7. PubMed ID: 9035112
    [No Abstract]   [Full Text] [Related]  

  • 10. Researchers caught in dispute over transgenic mice patents.
    Dalton R
    Nature; 2000 Mar; 404(6776):319-20. PubMed ID: 10746690
    [No Abstract]   [Full Text] [Related]  

  • 11. US Patent Office strategic plan may penalize biotechs.
    Robertson D
    Nat Biotechnol; 2003 Apr; 21(4):345-6. PubMed ID: 12665807
    [No Abstract]   [Full Text] [Related]  

  • 12. US court rules discovery of gene sequence 'not obvious'.
    Dickson D
    Nature; 1995 May; 375(6527):94. PubMed ID: 7753177
    [No Abstract]   [Full Text] [Related]  

  • 13. Proposal for US patent office could help cut waiting time.
    Smaglik P
    Nature; 2000 Jul; 406(6794):334. PubMed ID: 10935603
    [No Abstract]   [Full Text] [Related]  

  • 14. Errors in patent application sequence listings.
    Jones R
    Nat Biotechnol; 2003 Oct; 21(10):1239-40. PubMed ID: 14520406
    [No Abstract]   [Full Text] [Related]  

  • 15. OTA panel opens inquiry into patenting of genes.
    Macilwain C
    Nature; 1993 Apr; 362(6419):386. PubMed ID: 8464461
    [No Abstract]   [Full Text] [Related]  

  • 16. US courts narrow patent exemptions.
    Fox JL
    Nat Biotechnol; 2003 Aug; 21(8):834. PubMed ID: 12894182
    [No Abstract]   [Full Text] [Related]  

  • 17. Insulin patent dispute revisits old biotechnology battleground.
    Fox JL
    Nat Biotechnol; 1997 Apr; 15(4):307. PubMed ID: 9094114
    [No Abstract]   [Full Text] [Related]  

  • 18. Nontraditional publications and their effect on patentable inventions.
    Garabedian TE
    Nat Biotechnol; 2002 Apr; 20(4):401-2. PubMed ID: 11923849
    [No Abstract]   [Full Text] [Related]  

  • 19. Japan joins efforts to patent cDNA clones.
    Saegusa A
    Nature; 1999 Oct; 401(6753):520. PubMed ID: 10524612
    [No Abstract]   [Full Text] [Related]  

  • 20. Surprise US election results may boost biotech.
    Fox JL
    Nat Biotechnol; 2002 Dec; 20(12):1176. PubMed ID: 12454655
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.